Literature DB >> 21398226

Risk and rewards of fecal transplants.

Wendy Glauser.   

Abstract

Mesh:

Year:  2011        PMID: 21398226      PMCID: PMC3060180          DOI: 10.1503/cmaj.109-3806

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection.

Authors:  C A Duplessis; D You; M Johnson; A Speziale
Journal:  Infection       Date:  2011-12-08       Impact factor: 3.553

2.  Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.

Authors:  Ilan Youngster; Jenny Sauk; Christina Pindar; Robin G Wilson; Jess L Kaplan; Mark B Smith; Eric J Alm; Dirk Gevers; George H Russell; Elizabeth L Hohmann
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

3.  Low awareness but positive attitudes toward fecal transplantation in Ontario physicians.

Authors:  Madison Dennis; Mary Jane Salpeter; Susy Hota
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jan-Feb       Impact factor: 2.471

Review 4.  The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis.

Authors:  Yantian Cao; Bangjie Zhang; Yuanyuan Wu; Qingzhi Wang; Jie Wang; Fangfang Shen
Journal:  Gastroenterol Res Pract       Date:  2018-04-03       Impact factor: 2.260

5.  Intermittent fasting positively modulates human gut microbial diversity and ameliorates blood lipid profile.

Authors:  Muhammad Nadeem Khan; Sidra Irshad Khan; Madeeha Ilyas Rana; Arshad Ayyaz; Muhammad Yousaf Khan; Muhammad Imran
Journal:  Front Microbiol       Date:  2022-08-23       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.